Prostate Cancer Screening Using a Prostate-specific Antigen (PSA) Test or Digital Rectal Exam

See Also
Related Links

Find a patient education handout on this topic:

Recommendation

Do not routinely screen for prostate cancer using a prostate-specific antigen (PSA) test or digital rectal exam.

  • There is convincing evidence that PSA-based screening leads to substantial over-diagnosis of prostate tumors.
  • Many tumors will not harm patients, while the risks of treatment are significant.
  • Physicians should not offer or order PSA screening unless they are prepared to engage in shared decision making that enables an informed choice by patients.